Table 2

Clinical data of the 30 subjects who carry pathogenic FLCN mutation

Patient*SexAgeNo. and location of PTX episodesSkin lesionRenal diseaseFamily history of PTXFamily history of skin lesionFamily history of renal diseaseMedical history**Smoking history
JBR1(B1)F23(30)L(1) R(1)NoneNoneYesNoNoEndometriosis, PCOS, ovarian cyst, lipomaNever
JBR2(B2)F16(38)L(3) R(3)NoneNoneYesNoNoMyoma of the uterus,Ex-smoker 2.2 pack-years
JBR3(B3)F25(40)L(3)R(2)NoneNoneYesNoYesNoneNever
JBR4F49(80)R1NoneNoneNoNoNoNoneNever
JBR5(B6)F35(37)L(1)R(1)NoneNoneYesNoNoMyoma of the uterusNever
JBR6(B7)F28(38)L(2)R(1)NoneNoneYesNoYesVocal cord nodules, myoma of the uterus, carcinoma of the thyroid glandEx-smoker 0.6 pack-years
JBR7F52(53)L(3)NoneNoneYesNoNoBreast carcinomaNever
JBR8M33(33)R(1)NoneNoneNoNoNoNon-functioning adenoma of adrenal glandNever
JBR9F(31)Never (lung cyst)NoneNoneNoNoNoNoneNever
JBR10F78(85)L(1)R(1)NoneNoneNoNoNoColon cancerNever
JBR11M35(38)R(2)NoseNoneYesNoNoNoneNever
JBR12F57(68)L(1)R(2)Face, neckHydronephrosis (L)NoNoNoEndometriosisNever
JBR13F27(32)L(2)R(2)NoneNoneYesYesNoNoneNever
JBR14F27(31)L(1)R(6)NoneNoneNoNoNoNoneNever
JBR15F38(43)L(1)R(2)NoneAML(R)NoNoNoNoneEx-smoker 2.7 pack-years
JBR16F26(54)L(4)FFsNoneYesYesNoNoneNever
JBR17M34(34)L(5)R(2)NoneNoneNoNoNoNoneEx-smoker 18.8 pack-years
JBR18F16(46)L(4)R(4)NoneNoneYesNoNoNoneNever
JBR19Funknown(53)no details (2)NoneCancerYesNoNoNoneNever
JBR20F26(38)L(2)R(2)NoneNoneNoNoNoNoneEx-smoker 7.5 pack-years
JBR21F20(34)L(1)R(3)ChestNoneYesNoNoEndometriosisNever
JBR22F41(59)R(1)Face, neckNoneYesNoNoNoneNever
JBR23§M25(40)L(1)R(2)NoneNoneYesNoNoNoneNever
JBR24F52(52)L(1)NoneNoneNoNoNoNoneNever
JBR25M29(32)L(1)R(3)NoneNoneYesNoNoNoneNever
JBR26F21(23)L(2)R(2)NoneNoneNoNoNoNoneNever
JBR27F65(66)R(2)NoneNoneYesNoNoNoneNever
JBR28F24(44)L(2)R(1)NoneNoneYesNoNoNoneNever
JBR29F51(53)L(1)R(1)NeckNoneYesYesNoNoneEx-smoker 4.7 pack-years
JBR30M29(66)L(3)R(3)Seborrhoeic keratosisNoneYesNoNoGallbladder polypNever
  • JBR16 had FFs on the nose and JBR30 had seborrhoeic keratosis on the face and the neck.

  • Family history was obtained by an interview with the patient. FLCN mutation status of the family member was undetermined since they did not wish the genetic testing.

  • * The description in parentheses indicates the correspondence of the patient whose clinical data were already reported in the previous study.10

  • Age (years) at the first PTX is shown. Age at the enrolment in this study is indicated in parenthesis.

  • The number of pneumothorax episode in parentheses.

  • § The detailed clinical pictures of this case are described elsewhere.18

  • The locations of skin papules observed are indicated if the patient has no skin biopsy.

  • ** Only medical histories considered to be relevant for BHDS are listed.

  • FFs, fibrofolliculomas; L, left sided; PCOS, polycystic ovarian syndrome; PTX, pneumothorax; R, right sided.